Martin A. Lehr - Feb 25, 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Executive Officer, Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
2/25/2022, 03:38 PM
Previous filing
Dec 20, 2021
Next filing
Aug 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +254K $0.00 254K Feb 25, 2022 Common Stock 254K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.